Dr. Park received NIH R21

Dr. Park received R21 from National Institute of Aging with a project titled: Determining the role of tissue stiffness in the development of Alzheimer’s disease pathology. Congradulations! Updated: 12/15/2022

Samuel (Sam) Hurst joined TBRL as MS student

Sam joined our lab as a new MS student in September 2022. Welcome!

Lucas (Luke) Duncan joined TBRL as PhD student

Luke joined our lab as a new PhD student in May 2022. Welcome!

Adam Rocker’s PhD Thesis Defense

Congratulations, Dr. Adam Rocker! In August 2021, Adam defended his doctoral thesis titled, “A Sulfonated Thermoresponsive Injectable Gel for Sequential and Localized Release of Therapeutic Proteins to Protect Cardiac Function After a Myocardial Infarction.” Adam first started with our group in 2014 and earned his Master’s degree before continuing his studies into the PhD program. He has been large asset to the team, has trained many new members, and will be greatly missed. He now works as a material scientist at GelSana Therapeutics.

We moved!

As of October 2020, we have moved across the Anschutz Medical Campus from Research Complex 2 into the Bioscience 3 Building. This is an extension of the Fitzsimons Innovation Community plan, which is projected to spread across the old Fitzsimons Golf Course. BS3 offers our group an upgraded wet lab space housed next to the Center for Bioengineering. There are also numerous companies and CU affiliated spaces throughout the building.
by parktbrl | September 1st, 2021